RENEE KEMP: So what is the role of an anthracycline. Does it increase the benefits?
HOPE RUGO, MD: A big overview analysis has been done and is updated every two years. And this has looked at many, many women who have been treated on trials, clinical trials in Europe and in the United States. In those trials, they're able to gather data to try and make better sense of what treatments are better than other treatments. And from this big overview analysis as it's called, recent data has shown that anthracyclines given for women whose cancer has spread to nodes under their arm, axillary nodes, the anthracyclines improve survival and reduce the risk of recurrence compared to the non-anthracycline chemotherapy treatments.
RENEE KEMP: If you would, Dr. Rugo, discuss some of the side effects of adjuvant therapy.
HOPE RUGO, MD: You know the side effects depend, of course, very much on the treatment regimen. But chemotherapy that we use for breast cancer generally causes hair loss, some nausea and vomiting, some drop in the blood counts that's temporary. Sometimes there is a little discomfort in the mouth or change in taste and some fatigue. Those side effects are all temporary and most we've found can be significantly improved by just giving medications, paying very close attention, making sure that we react to problems that are occurring and give medications to prevent those problems.